Fluasterone, when compared to DHEA, is also a more potent G6PD inhibitor [42] as well as a more potent anti-glucocorticoid [54], anti-diabetic [18] and anti-obesity [10,42] agent, and has at least comparable activity in cancer chemoprevention [10-13]. The gene discussed is G6PD; the disease is cancer.